Posted on 10/04/2022 7:12:10 AM PDT by ConservativeMind
The presence of some fungal species in tumors predicts—and may even help drive—worse cancer outcomes.
The study provides a scientific framework to develop tests to delineate in tumors specific fungal species that are relevant for prediction of cancer progression and therapy. The results also point to the possibility of using antifungal treatments to augment conventional cancer treatments.
The idea that viruses and bacteria can trigger or accelerate cancer development is now well established. However, little is known about the cancer-related roles of fungi.
The analysis revealed that the DNA of certain fungal species are relatively abundant in some tumor types. These species include, in gastrointestinal tumors, Candida tropicalis and Candida albicans, which cause thrush and yeast infections; in lung tumors, species of the fungal genus Blastomyces; and in breast tumors, species of the fungus Malassezia.
Their analysis linked higher levels of Candida in gastrointestinal tumors to tumor gene activity promoting inflammation and reduced cell-to-cell adhesion—features associated with cancer's late-stage spread to distant organs, known as metastasis. Higher Candida levels for such tumors were also directly associated with a greater rate of metastasis.
The findings, according to the researchers, suggest that high levels of particular fungi in tumor biopsies might someday be used as biomarkers, indicating—for example—a higher metastasis risk.
Curiously, the researchers often detected DNA from the same Candida species in both gastrointestinal tumor samples and matched blood samples from the same patients.
Conceivably, tumor-associated fungi could also be targets for antifungal therapies to improve overall treatment outcomes. This prospect, however, hangs on an unresolved question: Do tumor-resident fungi help drive malignancy, perhaps by stoking inflammation, as some bacteria are known to do? Or are fungi associated with some tumors only because the tumors, as they become more advanced, provide an increasingly permissive environment for fungal growth?
(Excerpt) Read more at medicalxpress.com ...
This is a strange, but not novel, finding or expectation, and surely not all tumors have it. Others have found fungi in tumors, but it hasn’t gathered much traction, yet.
To prevent a fungus like Candida from gaining a greater foothold, consider some common sense changes, like a low Glycemic Index/Glycemic Load diet and minimizing things that compromise the immune system.
Natural Antifungals: The Strongest Candida Killers
https://www.thecandidadiet.com/guide-to-antifungals/
I can't vouch for the overall success of the Candida Diet, but at least some of it appears to work and the supplements described in the second link do have studies showing benefit.
Candida thrives on sugar.
Low/no sugar diets reduce tumors and mortality.
I’m just not seeing the correlation...
Here is information on the other fungi found.
Malassezia—Can it be Ignored?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533528/
Where does Blastomyces live?
https://www.cdc.gov/fungal/diseases/blastomycosis/causes.html
Any word from Tony Orlando?
“ Fenbendazole was also found to be effective at treating infections caused by Cryptococcus neoformans, an encapsulated fungus that causes meningoencephalitis in immunocompromised hosts. Several studies have hinted that fenbendazole also has anticancer properties. (Related: Moxibustion is an effective alternative cancer treatment, according to study.)”
Maybe other fungus as well
Low GI diet and ... didn’t I see an article in the last week that said Ivermectin had anti-cancer properties?
Ivermectin is a powerful anti-cancer remedy, 9 peer-reviewed studies conclude
https://ivermectinscience.com/2022-04-15-ivermectin-cancer-cure-nine-studies-conclude.html
thanks
bkmk
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.